These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Advances in the treatment of relapsing-remitting multiple sclerosis. Tanasescu R; Ionete C; Chou IJ; Constantinescu CS Biomed J; 2014; 37(2):41-9. PubMed ID: 24732658 [TBL] [Abstract][Full Text] [Related]
10. Dimethyl fumarate for relapsing-remitting multiple sclerosis. Drug Ther Bull; 2014 Sep; 52(9):105-8. PubMed ID: 25213591 [TBL] [Abstract][Full Text] [Related]
11. Siponimod (Mayzent)--a new drug for multiple sclerosis. Med Lett Drugs Ther; 2019 May; 61(1571):70-72. PubMed ID: 31169805 [No Abstract] [Full Text] [Related]
12. Cladribine (Mavenclad) for multiple sclerosis. Med Lett Drugs Ther; 2019 Jul; 61(1577):118-120. PubMed ID: 31381552 [No Abstract] [Full Text] [Related]
13. Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States. Mauskopf J; Fay M; Iyer R; Sarda S; Livingston T J Med Econ; 2016; 19(4):432-42. PubMed ID: 26707273 [TBL] [Abstract][Full Text] [Related]
15. Currently approved and emerging oral therapies in multiple sclerosis: An update for the ophthalmologist. Eckstein C; Bhatti MT Surv Ophthalmol; 2016; 61(3):318-32. PubMed ID: 26703886 [TBL] [Abstract][Full Text] [Related]
16. An update on new and emerging therapies for relapsing-remitting multiple sclerosis. Weinstock-Guttman B Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis. Fogarty E; Schmitz S; Tubridy N; Walsh C; Barry M Mult Scler Relat Disord; 2016 Sep; 9():23-30. PubMed ID: 27645339 [TBL] [Abstract][Full Text] [Related]
18. Novel Agents for Relapsing Forms of Multiple Sclerosis. Straus Farber R; Harel A; Lublin F Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285 [TBL] [Abstract][Full Text] [Related]